You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
未名醫藥(002581.SZ):兩名股東完成減持1.26%股份 擬繼續減持不超6%股份
格隆匯 11-04 18:16

格隆匯11月4日丨未名醫藥(002581.SZ)公佈,公司近日收到高寶林及一致行動人王明賢出具的《關於股份減持期限屆滿的吿知函》,截至2021年11月4日,高寶林、王明賢披露的減持計劃期限屆滿,二人於2021年5月14日-7月21日通過大宗交易及集中競價方式合計減持公司股份829.72萬股,佔公司總股本的1.26%。高寶林及王明賢當前合計持有公司股份7472.28萬股,佔公司總股本的11.33%。

另外,公司於今日收到高寶林、王明賢出具的《股份減持計劃吿知函》,二人計劃在該公吿披露之日起15個交易日後的6個月內通過集中競價、大宗交易方式或兩種方式相結合減持公司股份不超過3958.4135萬股,即不超過公司總股本的6%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account